vs
Side-by-side financial comparison of FORUM ENERGY TECHNOLOGIES, INC. (FET) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($346.4M vs $208.7M, roughly 1.7× FORUM ENERGY TECHNOLOGIES, INC.). HAEMONETICS CORP runs the higher net margin — 28.1% vs 2.2%, a 25.9% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 3.2%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $1.4M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (1.5% CAGR vs 0.8%).
Forum Energy Technologies is an American oilfield products company that provides products and services to the oil and gas, and renewable industries worldwide.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
FET vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.7M | $346.4M |
| Net Profit | $4.5M | $97.3M |
| Gross Margin | 29.2% | 57.2% |
| Operating Margin | 5.3% | 36.1% |
| Net Margin | 2.2% | 28.1% |
| Revenue YoY | 3.2% | 4.8% |
| Net Profit YoY | 300.4% | — |
| EPS (diluted) | $0.39 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $208.7M | $346.4M | ||
| Q4 25 | $202.2M | $339.0M | ||
| Q3 25 | $196.2M | $327.3M | ||
| Q2 25 | $199.8M | $321.4M | ||
| Q1 25 | $193.3M | $330.6M | ||
| Q4 24 | $201.0M | $348.5M | ||
| Q3 24 | $207.8M | $345.5M | ||
| Q2 24 | $205.2M | $336.2M |
| Q1 26 | $4.5M | $97.3M | ||
| Q4 25 | $2.1M | $44.7M | ||
| Q3 25 | $-20.6M | $38.7M | ||
| Q2 25 | $7.7M | $34.0M | ||
| Q1 25 | $1.1M | $58.0M | ||
| Q4 24 | $-103.5M | $37.5M | ||
| Q3 24 | $-14.8M | $33.8M | ||
| Q2 24 | $-6.7M | $38.4M |
| Q1 26 | 29.2% | 57.2% | ||
| Q4 25 | 30.2% | 59.7% | ||
| Q3 25 | 20.5% | 59.5% | ||
| Q2 25 | 29.7% | 59.8% | ||
| Q1 25 | 30.2% | 58.4% | ||
| Q4 24 | 31.1% | 55.5% | ||
| Q3 24 | 31.6% | 54.2% | ||
| Q2 24 | 30.7% | 52.0% |
| Q1 26 | 5.3% | 36.1% | ||
| Q4 25 | 6.3% | 19.9% | ||
| Q3 25 | -3.1% | 17.9% | ||
| Q2 25 | 7.4% | 16.8% | ||
| Q1 25 | 4.6% | 21.6% | ||
| Q4 24 | -53.1% | 16.9% | ||
| Q3 24 | 4.3% | 15.0% | ||
| Q2 24 | 3.9% | 11.8% |
| Q1 26 | 2.2% | 28.1% | ||
| Q4 25 | 1.0% | 13.2% | ||
| Q3 25 | -10.5% | 11.8% | ||
| Q2 25 | 3.9% | 10.6% | ||
| Q1 25 | 0.6% | 17.5% | ||
| Q4 24 | -51.5% | 10.8% | ||
| Q3 24 | -7.1% | 9.8% | ||
| Q2 24 | -3.3% | 11.4% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.25 | $0.95 | ||
| Q3 25 | $-1.76 | $0.81 | ||
| Q2 25 | $0.61 | $0.70 | ||
| Q1 25 | $0.09 | $1.17 | ||
| Q4 24 | $-8.41 | $0.74 | ||
| Q3 24 | $-1.20 | $0.66 | ||
| Q2 24 | $-0.54 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.5M | $245.4M |
| Total DebtLower is stronger | $153.7M | $1.2B |
| Stockholders' EquityBook value | $280.7M | $796.3M |
| Total Assets | $763.1M | $2.4B |
| Debt / EquityLower = less leverage | 0.55× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $37.5M | $245.4M | ||
| Q4 25 | $34.7M | $363.4M | ||
| Q3 25 | $31.7M | $296.4M | ||
| Q2 25 | $39.0M | $292.9M | ||
| Q1 25 | $31.1M | $306.8M | ||
| Q4 24 | $44.7M | $320.8M | ||
| Q3 24 | $33.3M | $299.3M | ||
| Q2 24 | $31.8M | $344.4M |
| Q1 26 | $153.7M | $1.2B | ||
| Q4 25 | $135.9M | $1.2B | ||
| Q3 25 | $140.0M | $1.2B | ||
| Q2 25 | $159.3M | $1.2B | ||
| Q1 25 | $171.4M | $1.2B | ||
| Q4 24 | $188.4M | — | ||
| Q3 24 | $231.5M | — | ||
| Q2 24 | $252.9M | — |
| Q1 26 | $280.7M | $796.3M | ||
| Q4 25 | $291.1M | $911.5M | ||
| Q3 25 | $297.3M | $849.2M | ||
| Q2 25 | $334.2M | $882.3M | ||
| Q1 25 | $320.0M | $820.8M | ||
| Q4 24 | $319.9M | $906.9M | ||
| Q3 24 | $443.5M | $878.9M | ||
| Q2 24 | $442.0M | $905.4M |
| Q1 26 | $763.1M | $2.4B | ||
| Q4 25 | $752.5M | $2.5B | ||
| Q3 25 | $770.1M | $2.4B | ||
| Q2 25 | $810.1M | $2.5B | ||
| Q1 25 | $790.1M | $2.5B | ||
| Q4 24 | $816.0M | $2.5B | ||
| Q3 24 | $973.7M | $2.5B | ||
| Q2 24 | $976.8M | $2.5B |
| Q1 26 | 0.55× | 1.53× | ||
| Q4 25 | 0.47× | 1.34× | ||
| Q3 25 | 0.47× | 1.44× | ||
| Q2 25 | 0.48× | 1.39× | ||
| Q1 25 | 0.54× | 1.49× | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | 0.52× | — | ||
| Q2 24 | 0.57× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.6M | $293.2M |
| Free Cash FlowOCF − Capex | $1.4M | $209.9M |
| FCF MarginFCF / Revenue | 0.7% | 60.6% |
| Capex IntensityCapex / Revenue | 0.1% | 9.5% |
| Cash ConversionOCF / Net Profit | 0.36× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $58.5M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.6M | $293.2M | ||
| Q4 25 | $22.4M | $93.6M | ||
| Q3 25 | $22.9M | $111.3M | ||
| Q2 25 | $15.8M | $17.4M | ||
| Q1 25 | $9.3M | $116.6M | ||
| Q4 24 | $38.5M | $43.8M | ||
| Q3 24 | $25.6M | $48.8M | ||
| Q2 24 | $23.1M | $-27.4M |
| Q1 26 | $1.4M | $209.9M | ||
| Q4 25 | $20.9M | $87.2M | ||
| Q3 25 | $21.5M | $106.3M | ||
| Q2 25 | $14.8M | $13.6M | ||
| Q1 25 | $7.2M | $100.9M | ||
| Q4 24 | $36.1M | $35.2M | ||
| Q3 24 | $24.3M | $39.4M | ||
| Q2 24 | $21.6M | $-33.1M |
| Q1 26 | 0.7% | 60.6% | ||
| Q4 25 | 10.3% | 25.7% | ||
| Q3 25 | 10.9% | 32.5% | ||
| Q2 25 | 7.4% | 4.2% | ||
| Q1 25 | 3.7% | 30.5% | ||
| Q4 24 | 18.0% | 10.1% | ||
| Q3 24 | 11.7% | 11.4% | ||
| Q2 24 | 10.5% | -9.8% |
| Q1 26 | 0.1% | 9.5% | ||
| Q4 25 | 0.8% | 1.9% | ||
| Q3 25 | 0.7% | 1.5% | ||
| Q2 25 | 0.5% | 1.2% | ||
| Q1 25 | 1.1% | 4.7% | ||
| Q4 24 | 1.2% | 2.5% | ||
| Q3 24 | 0.6% | 2.7% | ||
| Q2 24 | 0.7% | 1.7% |
| Q1 26 | 0.36× | 3.01× | ||
| Q4 25 | 10.83× | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | 2.05× | 0.51× | ||
| Q1 25 | 8.31× | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FET
| Drilling and Completions | $126.7M | 61% |
| Downhole | $50.6M | 24% |
| Production Equipment | $18.8M | 9% |
| Valve Solutions | $12.8M | 6% |
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
